Internal Medicine, Rheumatology · Kissimmee, FL
NPI
1811973696
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1400 W Oak St Ste Bandc
Kissimmee, FL, 34741
Phone (407) 343-5558
Groups this clinician bills Medicare through
Medicare paid, 2024
$351K
37,189 services
Medicare patients, 2024
241
Average age 73
Drug cost, 2024
$3.8M
6,588 prescriptions
Company payments, 2025
$3,915
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdul Aziz was code J0897 (injection, denosumab, 1 mg), 2,400 times for 26 patients. In total Abdul Aziz billed 37,189 services in 20 codes, and Medicare paid $351K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,400 | 26 | $20.64 | $50K |
| 99214 Office E&M - Established | Office | 564 | 218 | $90.41 | $51K |
| 96401 Chemotherapy Administration | Office | 170 | 34 | $53.04 | $9,017 |
| 99204 Office E&M - New | Office | 79 | 79 | $121.04 | $9,562 |
By year: 2022 $388K for 38,052 services; 2023 $365K for 40,380 services; 2024 $351K for 37,189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abdul Aziz prescribed most often to Medicare patients was Prednisone, with 1,226 prescriptions and refills. In total Abdul Aziz wrote 6,588 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,226 | 2,554 | 504 | $7,894 |
| Methotrexate Methotrexate Sodium | 960 | 2,302 | 362 | $18K |
| Leflunomide Generic | 609 | 1,459 | 221 | $48K |
| Hydroxychloroquine Sulfate Generic | 447 | 1,127 | 156 | $18K |
| Alendronate Sodium Generic | 390 | 989 | 161 | $2,619 |
| Gabapentin Generic | 357 | 876 | 167 | $6,141 |
| Folic Acid Generic | 237 | 612 | 95 | $1,182 |
| Sulfasalazine Generic | 221 | 522 | 92 | $6,832 |
| Baclofen Generic | 156 | 330 | 91 | $1,697 |
| Omeprazole Generic | 141 | 216 | 94 | $642 |
| Meloxicam Generic | 122 | 260 | 65 | $440 |
| Enbrel Sureclick Etanercept | 112 | 118 | 15 | $897K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 104 | 278 | 55 | $741 |
| Tramadol Hcl Generic | 104 | 108 | 59 | $397 |
| Allopurinol Generic | 94 | 258 | 33 | $804 |
Brand drugs: - claims; generic drugs: 5,786 claims; opioid claims: 141.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdul Aziz $3,915 ($3,915 in general payments such as food, travel and fees) from 17 companies. The largest payer was UCB, Inc. with $616.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 28 | $616 |
| Abbvie Inc. ABBV | 29 | $594 |
| Amgen Inc. AMGN | 33 | $580 |
| Pfizer Inc. PFE | 27 | $441 |
| Mallinckrodt Hospital Products Inc. | 11 | $290 |
| GlaxoSmithKline, LLC. GSK | 16 | $256 |
| Radius Health, Inc. | 10 | $248 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $226 |
| Janssen Biotech, Inc. JNJ | 10 | $209 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $140 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.